Thrombin inhibits the anti-myeloperoxidase and ferroxidase functions of ceruloplasmin: relevance in rheumatoid arthritis

Free Radical Biology and Medicine

Volumn 86, Issue , 2015, Pages 279-294

  Sokolov, Alexej V ^a,b   Acquasaliente, Laura ^c   Kostevich, Valeria A ^a   Frasson, Roberta ^c   Zakharova, Elena T ^a   Pontarollo, Giulia ^c   Vasilyev, Vadim B ^a,b   De Filippis, Vincenzo ^c  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

^b ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Ceruloplasmin; Myeloperoxidase; Oxidants; Protein proteininteraction; Proteolysis; Rheumatoid arthritis; Surface plasmonresonance; Thrombin

Indexed keywords

ARGININE; BETA 1 THROMBIN; CERULOPLASMIN; FIBRINOGEN; HIRUDIN; HIRUGEN; LYSINE; MYELOPEROXIDASE; PEPTIDE; PRETHROMBIN 2; PROTEINASE; PROTHROMBIN; SERINE; THROMBIN; THROMBIN DERIVATIVE; UNCLASSIFIED DRUG; VALINE; PEROXIDASE;

ARTICLE; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; AGED; CASE CONTROL STUDY; CHEMICAL STRUCTURE; CHEMISTRY; ENZYMOLOGY; MIDDLE AGED; PHYSIOLOGY; PROTEIN DOMAIN;

AGED; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CERULOPLASMIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, MOLECULAR; PEROXIDASE; PROTEIN INTERACTION DOMAINS AND MOTIFS; THROMBIN;

EID: 84937210303     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.05.016     Document Type: Article

References (67)

1. P Bielli, and L. Calabrese Structure to function relationships in ceruloplasmin: A 'moonlighting' protein Cell Mol. Life Sci. 59 2002 1413 1427
2. N Shukla, J Maher, J Masters, GD Angelini, and JY. Jeremy Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor? Atherosclerosis 187 2006 238 250
3. G Floris, R Medda, A Padiglia, and G. Musci The physiopathological significance of ceruloplasmin. A possible therapeutic approach Biochem. Pharmacol. 60 2000 1735 1741
4. S Shiva, X Wang, LA Ringwood, X Xu, S Yuditskaya, V Annavajjhala, H Miyajima, N. Hogg, ZL Harris, and MT. Gladwin Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis Nat. Chem. Biol. 2 2006 486 493
5. JD. Gitlin Transcriptional regulation of ceruloplasmin gene expression during inflammation J. Biol. Chem. 263 1988 6281 6287
6. I Bento, C Peixoto, VN. Zaitsev, and PF Lindley Ceruloplasmin revisited: Structural and functional roles of various metal cation-binding sites Acta Crystallogr. D Biol. Crystallogr 63 2007 240 248
7. VR Samygina, AV Sokolov, MO Pulina, HD Bartunik, and VB. Vasil'ev X-ray diffraction study of highly purified human ceruloplasmin Crystallogr. Reports 53 2008 655 662
8. IB Kingston, BL Kingston, and FW. Putnam Chemical evidence that proteolytic cleavage causes the heterogeneity present in human ceruloplasmin preparations Proc. Natl. Acad. Sci. U. S. A. 74 1977 5377 5381
9. AV Sokolov, EA Golenkina, VA Kostevich, VB Vasilyev, and GF. Sud'ina Interaction of ceruloplasmin and 5-lipoxygenase Biochemistry (Mosc) 75 2010 1464 1469
10. AV Sokolov, MO Pulina, KV Ageeva, OL Runova, ET Zakharova, and VB. Vasil'ev Identification of leukocyte cationic proteins that interact with ceruloplasmin Biochemistry (Mosc) 72 2007 872 877
11. AV Sokolov, KV Ageeva, VA Kostevich, MN Berlov, OL Runova, ET Zakharova, and VB. Vasilyev Study of interaction of ceruloplasmin with serprocidins Biochemistry (Mosc) 75 2010 1361 1367
12. VB. Vasilyev Interactions of caeruloplasmin with other proteins participating in inflammation Biochem. Soc. Trans. 38 2010 947 951
13. YS Park, K Suzuki, S Mumby, N Taniguchi, and JM. Gutteridge Antioxidant binding of caeruloplasmin to myeloperoxidase: Myeloperoxidase is inhibited, but oxidase, peroxidase and immunoreactive properties of caeruloplasmin remain intact Free Radic. Res. 33 2000 261 265
14. AV Sokolov, MO Pulina, KV Ageeva, MI Ayrapetov, MN Berlov, GN Volgin, AG Markov, PK Yablonsky, NI Kolodkin, ET Zakharova, and VB. Vasilyev Interaction of ceruloplasmin, lactoferrin, and myeloperoxidase Biochemistry (Mosc) 72 2007 409 415
15. AV Sokolov, VN Prozorovskii, and VB. Vasilyev Study of interaction of ceruloplasmin, lactoferrin, and myeloperoxidase by photon correlation spectroscopy Biochemistry (Mosc) 74 2009 1225 1227
16. AL Chapman, TJ Mocatta, S Shiva, A Seidel, B Chen, I Khalilova, ME Paumann-Page, GN Jameson, CC Winterbourn, and AJ. Kettle Ceruloplasmin is an endogenous inhibitor of myeloperoxidase J. Biol. Chem. 288 2013 6465 6477
17. SJ. Klebanoff Myeloperoxidase: Friend and foe J. Leukoc. Biol. 77 2005 598 625
18. OM Panasenko, IV Gorudko, and AV. Sokolov Hypochlorous acid as a precursor of free radicals in living systems Biochemistry (Mosc) 78 2013 1466 1489
19. LK Stamp, I Khalilova, JM Tarr, R Senthilmohan, R Turner, RC Haigh, PG Winyard, and AJ. Kettle Myeloperoxidase and oxidative stress in rheumatoid arthritis Rheumatology (Oxford) 51 2012 1796 1803
20. DL Scott, F Wolfe, and TW. Huizinga Rheumatoid arthritis Lancet 376 2010 1094 1108
21. AK So, PA Varisco, B Kemkes-Matthes, C Herkenne-Morard, V Chobaz-Peclat, JC Gerster, and N. Busso Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways J. Thromb. Haemost. 1 2003 2510 2515
22. S Nakano, T Ikata, I Kinoshita, J Kanematsu, and S. Yasuoka Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis Clin. Exp. Rheumatol. 17 1999 161 170
23. E. Di Cera Thrombin interactions Chest 124 2003 11 S 17SS
24. JA. Huntington Molecular recognition mechanisms of thrombin J. Thromb. Haemost. 3 2005 1861 1872
25. + binding on the conformation, stability and molecular recognition properties of thrombin Biochem. J. 390 2005 485 492
26. N Pozzi, L Acquasaliente, R Frasson, A Cristiani, S Moro, A Banzato, V Pengo, GL Scaglione, A Arcovito, R De Cristofaro, and V. De Filippis β2-glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions J. Thromb. Haemost. 11 2013 1093 1102
27. S Lancellotti, S Rutella, V De Filippis, N Pozzi, B Rocca, and R. De Cristofaro Fibrinogen-elongated gamma chain inhibits thrombin-induced platelet response, hindering the interaction with different receptors J. Biol. Chem. 283 2008 30193 30204
28. AV Sokolov, VA Kostevich, DN Romanico, ET Zakharova, and VB. Vasilyev Two-stage method for purification of ceruloplasmin based on its interaction with neomycin Biochemistry (Mosc) 77 2012 631 638
29. DP Naughton, J Knappitt, K Fairburn, K Gaffney, DR Blake, and M. Grootveld Detection and investigation of the molecular nature of low-molecular-mass copper ions in isolated rheumatoid knee-joint synovial fluid FEBS Lett. 361 1995 167 172
30. AV Sokolov, KV Ageeva, OS Cherkalina, MO Pulina, ET Zakharova, VN Prozorovskii, DV Aksenov, VB Vasilyev, and OM. Panasenko Identification and properties of complexes formed by myeloperoxidase with lipoproteins and ceruloplasmin Chem. Phys. Lipids 163 2010 347 355
31. AV Sokolov, KV Ageeva, MO Pulina, OS Cherkalina, VR Samygina, II Vlasova, OM Panasenko, ET Zakharova, and VB. Vasilyev Ceruloplasmin and myeloperoxidase in complex affect the enzymatic properties of each other Free Radic. Res. 42 2008 989 998
32. AV Sokolov, MO Pulina, KV Ageeva, OS Tcherkalina, ET Zakharova, and VB. Vasilyev Identification of complexes formed by ceruloplasmin with matrix metalloproteinases 2 and 12 Biochemistry (Mosc) 74 2009 1388 1392
33. AV Sokolov, KV Ageeva, MO Pulina, ET Zakharova, and VB. Vasilyev Effect of lactoferrin on oxidative features of ceruloplasmin Biometals 22 2009 521 529
34. IV Gorudko, OS Cherkalina, AV Sokolov, MO Pulina, ET Zakharova, VB Vasil'ev, SN Cherenkevich, and OM. Panasenko New approaches to the measurement of the concentration and peroxidase activity of myeloperoxidase in human blood plasma Bioorg. Khim. 35 2009 629 639
35. W Li, DJ Johnson, TE Adams, N Pozzi, V De Filippis, and JA. Huntington Thrombin inhibition by serpins disrupts exosite II J. Biol. Chem. 285 2010 38621 38629
36. J Hofsteenge, PJ Braun, and SR. Stone Enzymatic properties of proteolytic derivatives of human alpha-thrombin Biochemistry 27 1988 2144 2151
37. S Donnini, F Finetti, S Francese, F Boscaro, FR Dani, F Maset, R Frasson, M Palmieri, M Pazzagli, V De Filippis, E Garaci, and M. Ziche A novel protein from the serum of python sebae, structurally homologous with type-gamma phospholipase A(2) inhibitor, displays antitumour activity Biochem. J. 440 2011 251 262
38. JC Fredenburgh, AR Stafford, and JI. Weitz Evidence for allosteric linkage between exosites 1 and 2 of thrombin J. Biol. Chem. 272 1997 25493 25499
39. G. Vriend WHAT IF: A molecular modeling and drug design program J. Mol. Graph. 8 52-6 1990 29
40. D Kozakov, D Beglov, T Bohnuud, SE Mottarella, B Xia, DR Hall, and S. Vajda How good is automated protein docking? Proteins 81 2013 2159 2166
41. VR Samygina, AV Sokolov, G Bourenkov, MV Petoukhov, MO Pulina, ET Zakharova, VB Vasilyev, H Bartunik, and DI. Svergun Ceruloplasmin: Macromolecular assemblies with iron-containing acute phase proteins PLoS One 8 2013 e67145
42. W Bode, D Turk, and A. Karshikov The refined 1.9-A X-ray crystal structure of D-phe-pro-arg chloromethylketone-inhibited human alpha-thrombin: Structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships Protein Sci. 1 1992 426 471
43. F Fogolari, A Corazza, V Yarra, A Jalaru, P Viglino, and G. Esposito Bluues: A program for the analysis of the electrostatic properties of proteins based on generalized born radii BMC Bioinformatics 13 Suppl 4 2012 S18-2105-13-S4-S18
44. F. Markwardt Hirudin and derivatives as anticoagulant agents Thromb. Haemost. 66 1991 141 152
45. A Vindigni, V De Filippis, G Zanotti, C Visco, G Orsini, and A. Fontana Probing the structure of hirudin from hirudinaria manillensis by limited proteolysis. Isolation, characterization and thrombin-inhibitory properties of N-terminal fragments Eur. J. Biochem. 226 1994 323 333
46. V De Filippis, VB Vassiliev, M Beltramini, A Fontana, B Salvato, and VS. Gaitskhoki Evidence for the molten globule state of human apo-ceruloplasmin Biochim. Biophys. Acta 1297 1996 119 123
47. I Marty, V Peclat, G Kirdaite, R Salvi, A So, and N. Busso Amelioration of collagen-induced arthritis by thrombin inhibition J. Clin. Invest. 107 2001 631 640
48. PK Stamenova, T Marchetti, and I. Simeonov Efficacy and safety of topical hirudin (hirudex): A double-blind, placebo-controlled study Eur. Rev. Med. Pharmacol. Sci. 5 2001 37 42
49. R Squitti, CC Quattrocchi, C Salustri, and PM. Rossini Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's disease Prion 2 2008 23 27
50. Real-Time Analysis of Biomolecular interactions - Applications of Biacore K. Nagata, and H. Handa 2000 Springer-Verlag Tokyo, Japan
51. C Bertonati, B Honig, and E. Alexov Poisson-boltzmann calculations of nonspecific salt effects on protein-protein binding free energies Biophys. J. 92 2007 1891 1899
52. V De Filippis, G Colombo, I Russo, B Spadari, and A. Fontana Probing the hirudin-thrombin interaction by incorporation of noncoded amino acids and molecular dynamics simulation Biochemistry 41 2002 13556 13569
53. BC Lechtenberg, DJ Johnson, SM Freund, and JA. Huntington NMR resonance assignments of thrombin reveal the conformational and dynamic effects of ligation Proc. Natl. Acad. Sci. U. S. A. 107 2010 14087 14092
54. PE Bock, P Panizzi, and IM. Verhamme Exosites in the substrate specificity of blood coagulation reactions J. Thromb. Haemost. 5 Suppl 1 2007 81 94
55. KG Mann, K Brummel-Ziedins, T Orfeo, and S. Butenas Models of blood coagulation Blood Cells Mol. Dis. 36 2006 108 117
56. N Pozzi, Z Chen, DW Gohara, W Niu, T Heyduk, and E. Di Cera Crystal structure of prothrombin reveals conformational flexibility and mechanism of activation J. Biol. Chem. 288 2013 22734 22744
57. N Pozzi, Z Chen, F Zapata, LA Pelc, S Barranco-Medina, and E. Di Cera Crystal structures of prethrombin-2 reveal alternative conformations under identical solution conditions and the mechanism of zymogen activation Biochemistry 50 2011 10195 10202
58. VN Prozorovski, LG Rashkovetski, MM Shavlovski, VB Vasiliev, and SA. Neifakh Evidence that human ceruloplasmin molecule consists of homologous parts Int. J. Pept. Protein Res 19 1982 40 53
59. A Fontana, P Polverino de Laureto, V De Filippis, E Scaramella, and M. Zambonin Probing the partly folded states of proteins by limited proteolysis Fold. Des. 2 1997 R17 R26
60. M Gallwitz, M Enoksson, M Thorpe, and L. Hellman The extended cleavage specificity of human thrombin PLoS One 7 2012 e31756
61. MJ Flick, X Du, DP Witte, M Jirouskova, DA Soloviev, SJ Busuttil, EF Plow, and JL. Degen Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo J. Clin. Invest. 113 2004 1596 1606
62. IV Gorudko, DV Grigorieva, EV Shamova, VA Kostevich, AV Sokolov, EV Mikhalchik, SN Cherenkevich, J Arnhold, and OM. Panasenko Hypohalous acid-modified human serum albumin induces neutrophil NADPH oxidase activation, degranulation, and shape change Free Radic. Biol. Med. 68 2014 326 334
63. R Morris, PG Winyard, LF Brass, DR Blake, and CJ. Morris Thrombin receptor expression in rheumatoid and osteoarthritic synovial tissue Ann. Rheum. Dis. 55 1996 841 843
64. SP Kastl, WS Speidl, KM Katsaros, C Kaun, G Rega, A Assadian, GW Hagmueller, M Hoeth, R De Martin, Y Ma, G Maurer, K Huber, and J. Wojta Thrombin induces the expression of oncostatin M via AP-1 activation in human macrophages: A link between coagulation and inflammation Blood 114 2009 2812 2818
65. YH Yang, P Hall, CB Little, AJ Fosang, G Milenkovski, L Santos, J Xue, P Tipping, and EF. Morand Reduction of arthritis severity in protease-activated receptor-deficient mice Arthritis Rheum. 52 2005 1325 1332
66. JA Swain, V Darley-Usmar, and JM. Gutteridge Peroxynitrite releases copper from caeruloplasmin: Implications for atherosclerosis FEBS Lett. 342 1994 49 52
67. J Aaseth, M Haugen, and O. Forre Rheumatoid arthritis and metal compounds - perspectives on the role of oxygen radical detoxification Analyst 123 1998 3 6